Meet Mr. NVX‑CoV2373!

And what is this one? Who is this? Is that a booger? What is this? A new Pizza Additive? Yes, what is it? It’s super cool and it’s a proprietary Patented Process owned by Novavax Inc. And yes, it may be going into our Arms towards the end of 2020. But why? WHY?

SO WE WON’T DIE! SO WE DON’T DIE OF COVID-19 IS WHY!

NVX-CoV2373 Coronavirus Vaccine Description

https://www.precisionvaccinations.com/vaccines/nvx-cov2373-sars-cov-2-vaccine

NVX-CoV2373 is a prefusion protein coronavirus vaccine candidate made using Novavax’s proprietary nanoparticle technology, Matrix-M, which is an adjuvant to enhance immune responses and stimulate high levels of neutralizing antibodies.

And what’s so special about this? Here’s a Timeline- just click on the following-

https://www.precisionvaccinations.com/vaccines/nvx-cov2373-sars-cov-2-vaccine

BUT SUPER SECRET PATENTED TECHNOLOGIES ARE BEING USED-

https://www.novavax.com/our-unique-technology

Recombinant Nanoparticle Vaccine Technology

Our recombinant nanoparticle vaccine technology combines the power and speed of genetic engineering to efficiently produce a new class of highly immunogenic particles that target a variety of viral pathogens. Our recombinant vaccine engineering takes a new approach to provide robust and functional immunity, which may be more efficacious than naturally occurring immunity or traditional vaccines. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats.

https://www.kbtx.com/2020/07/27/trump-announces-bio-manufacturing-center-at-texas-am-part-of-warp-speed-production-of-covid-19-vaccine-candidate/

Bio-manufacturing center at Texas A&M part of ‘Warp Speed” production of COVID-19 vaccine candidate

FUJIFILM Diosynth Biotechnologies at CIADM to mass produce for Novavax Inc.

https://today.tamu.edu/2020/07/27/college-station-bio-manufacturing-center-to-produce-covid-19-vaccines/

College Station Bio-Manufacturing Center To Produce COVID-19 Vaccines

FUJIFILM Diosynth Biotechnologies, a Texas A&M University System subcontractor, will mass produce vaccines as part of an agreement between the federal government and the Center for Innovation in Advanced Development and Manufacturing.

By Texas A&M University System Communications Staff JULY 27, 2020

Fujifilm-diosynth-biotechnologies-careers-texas-header-1024x853

FUJIFILM Diosynth Biotechnologies in College Station, Texas.

https://fujifilmdiosynth.com/careers/texas/living-in-college-station-texas/

This is really cool News about where millions of a New Potential COVID-19 Vaccine will be manufactured. Right HERE in TEXAS!

THANKS TO TEXAS A&M UNIVERSITY!

Now, we’ve all got its “Vaccine Name” and it’s just wait and see how the PHASE I, PHASE II AND PHASE III (Human) TRIALS all go.

PHASE I (non-human) RESULTS-https://www.biorxiv.org/content/10.1101/2020.06.29.178509v1.full

Vaccinestudier – Overblik over planlagte og igangværende humane studier af vacciner til COVID-19